REGISTERED NUMBER: 07430530 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

TFR PHARMA LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

N W Raymond

Mrs M Raymond

SECRETARY:

REGISTERED OFFICE:

1&2 Merlins Court

Winch Lane

Haverfordwest

United Kingdom

Pembrokeshire

SA61 1SB

REGISTERED NUMBER:

07430530 (England and Wales)

ACCOUNTANTS:

L M Griffiths & Co Limited

Chartered Certified Accountants

1&2 Merlins Court

Winch Lane

Haverfordwest

Pembrokeshire

SA61 1SB

FIXED ASSETS

Intangible assets

4

345,549

483,769

Tangible assets

5

89,606

122,563

435,155

606,332

CURRENT ASSETS

Stocks

131,786

137,023

Debtors

6

1,593,648

1,184,683

Cash at bank

116,884

373,123

1,842,318

1,694,829

CREDITORS

Amounts falling due within one year

7

989,588

1,424,812

NET CURRENT ASSETS

852,730

270,017

TOTAL ASSETS LESS CURRENT LIABILITIES

1,287,885

876,349

CREDITORS

Amounts falling due after more than one year

8

(880,109

)

(593,292

)

PROVISIONS FOR LIABILITIES

(22,402

)

(30,668

)

NET ASSETS

385,374

252,389

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

385,274

252,289

385,374

252,389

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 August 2026 and were signed on its behalf by:

N W Raymond - Director

1.	STATUTORY INFORMATION

Tfr Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2024 - 26 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 December 2024

and 30 November 2025

1,341,099

AMORTISATION

At 1 December 2024

857,330

Charge for year

138,220

At 30 November 2025

995,550

NET BOOK VALUE

At 30 November 2025

345,549

At 30 November 2024

483,769

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 December 2024

303,611

Additions

794

At 30 November 2025

304,405

DEPRECIATION

At 1 December 2024

181,048

Charge for year

33,751

At 30 November 2025

214,799

NET BOOK VALUE

At 30 November 2025

89,606

At 30 November 2024

122,563

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

937,991

995,660

Other debtors

655,657

189,023

1,593,648

1,184,683

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

92,858

118,918

Hire purchase contracts

11,998

11,998

Trade creditors

494,859

487,923

Taxation and social security

129,256

110,899

Other creditors

260,617

695,074

989,588

1,424,812

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

844,115

546,300

Hire purchase contracts

35,994

46,992

880,109

593,292

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 November 2025 and 30 November 2024:

2025

2024

£

£

N W Raymond and Mrs M Raymond

Balance outstanding at start of year

24,910

-

Amounts advanced

514,022

24,910

Amounts repaid

(37,363

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

501,569

24,910